Tian et al. found that ARHGAP5 expression was significantly increased in metastatic CRC tissues and negatively correlated with overall survival rates of patients, and ARHGAP5 promoted CRC cell EMT by negatively regulating RhoA activity. Here, ARHGAP5 is linked to colorectal carcinoma.